Home › Funds › Nippon Life Global Investors Americas, Inc. › ABBV

Nippon Life Global Investors Americas, Inc. position in ABBV

ABBVIE INC · Health Care

Nippon Life Global Investors Americas, Inc. reported holding 59,950 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$15.7M, representing 0.63% of its reported portfolio and ranking #44 among its reported holdings. Nippon Life Global Investors Americas, Inc. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)59.95K sh
Reported value held$15.68M
Portfolio Weight0.63%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Nippon Life Global Investors Americas, Inc.'s ABBV position evolved

Nippon Life Global Investors Americas, Inc. first disclosed a stake in ABBV in Q3 2023 at 44,620 shares (US$6.7M). The position peaked in Q3 2026 at 59,950 shares, worth US$15.7M. Across 13 filings, Nippon Life Global Investors Americas, Inc. increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 59,950 shares valued at US$15.7M — an increase of 17,870 shares quarter over quarter.. Notable position changes include a 42% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 44.62K $6.65M New
Q4 2023 44.62K $6.91M Hold
Q1 2024 53.46K $9.74M Add
Q2 2024 59.36K $10.18M Add
Q3 2024 54.36K $10.74M Reduce
Q4 2024 43.26K $7.69M Reduce
Q1 2025 44.68K $9.36M Add
Q2 2025 44.94K $8.34M Add
Q3 2025 47.97K $11.11M Add
Q4 2025 46.25K $10.57M Reduce
Q1 2026 52.35K $11.39M Add
Q2 2026 42.08K $10.59M Reduce
Q3 2026 59.95K $15.68M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Nippon Life Global Investors Americas, Inc. held ABBV?

Nippon Life Global Investors Americas, Inc. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Nippon Life Global Investors Americas, Inc.'s current position in ABBV?

As of Q3 2026, Nippon Life Global Investors Americas, Inc. holds 59.95K shares of ABBV (ABBVIE INC), valued at $15.68M, representing 0.63% of its reported portfolio and ranking #44.

Has Nippon Life Global Investors Americas, Inc. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Nippon Life Global Investors Americas, Inc. increased its position in ABBV. The position peaked in Q3 2026 at 59.95K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.